维生素D3补充对体成分的影响:VITAL试验
结果显示,维生素D3补充对体重、BMI、腰围及脂肪和瘦组织 measures 均无显著影响,但在基线BMI正常的参与者中略微改善体脂百分比(交互作用P=0.04)。结论认为,在一般老年人群中,每日补充维生素D3并未改善体重或体成分。
要点
- 每日补充维生素D3 2000 IU持续2年未改善老年人群的体重或体成分。
- 在基线BMI正常者中,维生素D3可能略微改善体脂百分比,但需进一步研究。
- 效应未受性别、种族、脂肪质量指数或基线25(OH)D水平影响。
核心结论
- 在一般老年人群中,每日补充维生素D3与安慰剂相比未改善体重或体成分。
- 补充维生素D3可能对基线BMI正常者的体脂百分比有轻微益处,值得进一步研究。
研究设计与样本
- 本辅助研究在子队列中进行,771名参与者(男性≥50岁,女性≥55岁)完成基线和2年随访的体成分评估(保留率89%)。
- 干预为维生素D3(2000 IU/天)和/或Omega-3脂肪酸(1克/天)。
主要发现
- 维生素D3补充与安慰剂相比,对体重、BMI、腰围及脂肪和瘦组织 measures 均无显著影响。
- 效应未因性别、种族/族裔、脂肪质量指数或基线总25(OH)D或游离25(OH)D水平而改变。
- 在基线BMI正常的参与者中,维生素D3补充略微改善体脂百分比,但在超重或肥胖者中无此效果(交互作用P=0.04)。
关键数值与推荐
- 主要结局为2年内体重、BMI、腰围及双能X线吸收法测定的总脂肪和区域脂肪及瘦组织 measures 的变化。
临床怎么用
- 对于一般老年人群,不应期望通过每日补充维生素D3 2000 IU来改善体重或体成分。
- 对于基线BMI正常者,维生素D3补充可能对体脂百分比有轻微益处,但需个体化评估。
局限性
- 研究为辅助子队列分析,样本量有限(771人),可能影响统计效能。
- 随访时间仅为2年,长期效应未知。
- 参与者为老年人群,结果可能不适用于其他年龄组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Although observational studies show inverse associations between vitamin D status and body weight/adiposity, there are few large randomized controlled trials (RCTs) investigating this relationship. OBJECTIVE: To determine whether vitamin D3 supplementation lowers weight or improves body composition. DESIGN: The VITamin D and OmegA-3 TriaL (VITAL) was a double-blinded, placebo-controlled RCT including 25 871 US adults. This ancillary study was completed in a sub-cohort that underwent body composition assessments at baseline and 2-year follow-up (89% retention). SETTING: Harvard Clinical and Translational Science Center in Boston. PARTICIPANTS: 771 participants (men ≥ 50 and women ≥ 55 years). INTERVENTIONS: 2 × 2 factorial design of supplemental vitamin D3 (2000 IU/day) and/or omega-3 fatty acids (1 g/day). MAIN OUTCOME MEASURES: Endpoints were 2-year changes in weight, body mass index (BMI), waist circumference, and total and/or regional fat and lean tissue measures determined by dual-energy X-ray absorptiometry. Effect modification by clinical variables and total and free 25-hydroxyvitamin D (25[OH]D) levels was explored. RESULTS: There were no effects of supplemental vitamin D3vs placebo on weight, BMI, or measures of adiposity and lean tissue. Effects did not vary by sex, race/ethnicity, fat mass index, or baseline total or free 25(OH)D levels. Vitamin D3 supplementation did slightly improve body fat percentage in participants with normal BMI at baseline, but not in the overweight or obese (P for interaction = 0.04). CONCLUSIONS: Daily vitamin D3 supplementation vs placebo in the general older population did not improve weight or body composition. Whether supplemental vitamin D3 may benefit individuals with normal BMI warrants further study.
引用
- Chou SH, Murata EM, Yu C, et al. Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 TriaL (VITAL). J Clin Endocrinol Metab. 2021. PMID: 33513226. doi:10.1210/clinem/dgaa981
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。